GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Should it be a buyout, or could it be also a merger?<

The “change of control” provisions apply to any all-cash buyout and to any stock-for-stock merger where GTC’s shareholders end up owning less than 50% of the merged entity.

>And what about the possibility of a RS. I cannot bring that in line with a buyout.<

If a buyout were in the cards, there would be no need for a reverse split.